Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1P 140----1件: 49 💬
2P-1037----1件: 299 💬
3P-188 NF----1件: 113 💬
4P-552----1件: 53 💬
5P144----1件: 51 💬
6P144 cream----1件: 51 💬
7P144 Cytokine Inhibitor----1件: 51 💬
8P144 Cytokines Inhibitors----1件: 51 💬
9P144 DIGNA CREAM----1件: 51 💬
10P144. Cytokines Inhibitors----1件: 51 💬
11P28GST----1件: 96 💬
12P2B001----1件: 6 💬
13P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline
3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬
4件: DRD2,
DRD3,
DRD4,
MAOB 💬
18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
14P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg),2件: Pramipexole,
Rasagiline
3件: Pramipexole ,
Rasagiline ,
Rasagiline tartrate 💬
4件: DRD2,
DRD3,
DRD4,
MAOB 💬
18件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
15P32----1件: 37 💬
16P32/98----1件: 37 💬
17P32/98 3%----1件: 37 💬
18P38 (4) Map Kinase Inhibitor----1件: 46 💬
19P38 Inhibitor (4)----1件: 46 💬
20P38 Inhibitor (4) 150mg----1件: 46 💬
21P38 Inhibitor (4) 25mg----1件: 46 💬
22P38 Inhibitor (4) 300mg----1件: 46 💬
23P38 Inhibitor (4) 50mg----1件: 46 💬
24P38 Inhibitor (4) 75mg----1件: 46 💬
25P38 Map Kinase Inhibitor----1件: 46 💬
26P38(4) Map Kinase Inhibitor----1件: 46 💬
27PA101----1件: 85 💬
28PAAG15----1件: 299 💬
29Pabinafusp alfa1件: Pabinafusp alfa1件: Pabinafusp alfa 💬 2件: IDS,
TFRC 💬
8件: Endocytosis, Ferroptosis, Glycosaminoglycan degradation, HIF-1 signaling pathway, Hematopoietic cell lineage, Lysosome, Metabolic pathways, Phagosome 💬1件: 19 💬
30Paclitaxel1件: Paclitaxel1件: Paclitaxel 💬 9件: TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬
10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬2件: 46, 85 💬
31Padsevonil1件: Padsevonil1件: Padsevonil 💬 3件: SV2A,
SV2B,
SV2C 💬
1件: ECM-receptor interaction 💬1件: 149 💬
32PAH----3件: 49, 53, 86 💬
33PAH medication----1件: 86 💬
34PAH Therapies----1件: 86 💬
35Palifermin1件: Palifermin1件: Palifermin 💬 1件: FGFR2 💬 13件: Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬5件: 13, 36, 38, 39, 65 💬
36Palmitate1件: Palmitic Acid1件: Palmitic acid 💬 --1件: 63 💬
37Palmitoleic Acid1件: Palmitoleic Acid---1件: 97 💬
38Palmitoylethanolamide1件: Palmidrol1件: Palmidrol 💬 --1件: 2 💬
39Palopegteriparatide----1件: 235 💬
40Palopegteriparatide (TransCon PTH)----1件: 235 💬
41PALOVAROTENE1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
42PALOVAROTENE - 1.5mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
43PALOVAROTENE - 10 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
44PALOVAROTENE - 1mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
45PALOVAROTENE - 2 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
46PALOVAROTENE - 2.5 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
47PALOVAROTENE - 3 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
48PALOVAROTENE - 4 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
49PALOVAROTENE - 5 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
50PALOVAROTENE 1.5 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
51Palovarotene dose level 11件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
52Palovarotene dose level 21件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
53Palovarotene dose level 31件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
54Palovarotene dose level 41件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
55PALOVAROTENE-2 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
56PALOVAROTENE-3 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
57PALOVAROTENE-4 mg1件: Palovarotene1件: Palovarotene 💬 1件: RARG 💬 -1件: 272 💬
58Palynziq1件: Pegvaliase1件: Pegvaliase 💬 1件: PAH 💬 5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
59Pamidronate1件: Pamidronic acid1件: Pamidronic acid 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬3件: 270, 271, 274 💬
60Pamidronate (Aredia)1件: Pamidronic acid1件: Pamidronic acid 💬 1件: FDPS 💬 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 274 💬
61PAMREVLUMAB1件: Pamrevlumab1件: Pamrevlumab 💬 1件: CCN2 💬 2件: Apelin signaling pathway, Hippo signaling pathway 💬2件: 85, 113 💬
62Pamrevlumab (FG-3019)1件: Pamrevlumab1件: Pamrevlumab 💬 1件: CCN2 💬 2件: Apelin signaling pathway, Hippo signaling pathway 💬1件: 113 💬
63Panax Quinquefolius1件: Panax quinquefolius whole---1件: 46 💬
64Pancreas Powder----1件: 299 💬
65Pancrease----1件: 299 💬
66PANCREASE MT----1件: 299 💬
67Pancrease MT 10.5, or MT 21----1件: 299 💬
68PANCREASLIPASE----1件: 299 💬
69Pancreatic enzyme(Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose Tablets, Glucophage, Glimepirde Tablets)2件: Acarbose,
Pancrelipase
2件: Acarbose ,
Pancrelipase 💬
5件: AMY2A,
AMY2B,
GAA,
GANC,
MGAM 💬
7件: Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Metabolic pathways, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬1件: 298 💬
70Pancreatic enzymes----1件: 298 💬
71Pancreatin1件: Pancrelipase1件: Pancrelipase 💬 --2件: 298, 299 💬
72PANCREATIN (PAncreas Powder)1件: Pancrelipase1件: Pancrelipase 💬 --1件: 299 💬
73PANCREATINA----1件: 299 💬
74PANCREATINA (Páncreas Polvo----1件: 299 💬
75PANCREATINA (Páncreas Polvo)----1件: 299 💬
76PANCREAZE----1件: 299 💬
77PANCREAZE®----1件: 299 💬
78PANCRECARB® (pancrelipase)1件: Pancrelipase1件: Pancrelipase 💬 --1件: 299 💬
79Pancrelipase2件: Pancrelipase,
Pancrelipase amylase
1件: Pancrelipase 💬 --2件: 298, 299 💬
80PANCRELIPASE AMYLASE2件: Pancrelipase,
Pancrelipase amylase
1件: Pancrelipase 💬 --1件: 299 💬
81Pancrelipase Delayed Release1件: Pancrelipase1件: Pancrelipase 💬 --1件: 299 💬
82Pancrelipase Delayed Release Capsule1件: Pancrelipase1件: Pancrelipase 💬 --2件: 298, 299 💬
83Pancrelipase Microtablets1件: Pancrelipase1件: Pancrelipase 💬 --1件: 299 💬
84Pancrelipase with bicarbonate1件: Pancrelipase1件: Pancrelipase 💬 --1件: 299 💬
85Pancrelipase/Pancreas Powder1件: Pancrelipase1件: Pancrelipase 💬 --2件: 298, 299 💬
86Pandemrix,----1件: 46 💬
87Panhematin1件: Hemin1件: Hemin 💬 2件: ALAS1,
ALAS2 💬
4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin metabolism 💬1件: 254 💬
88Pankreatin----1件: 299 💬
89Pantethine1件: Pantethine1件: Pantethine 💬 --1件: 120 💬
90Pantoprazole1件: Pantoprazole1件: Pantoprazole 💬 2件: ATP4A,
ATP4B 💬
4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬2件: 13, 65 💬
91Pantoprazolo 20 mg gastro-resistant tablets----1件: 65 💬
92PANZYGA----1件: 14 💬
93Panzytrat----1件: 298 💬
94Panzytrat 25.000----1件: 298 💬
95Panzytrat 25.000 FIP-E units of Lipase----1件: 298 💬
96PANZYTRAT 25000----1件: 299 💬
97Panzytrat® 25,000----1件: 299 💬
98Panzytrat® ok----1件: 299 💬
99Paquinimod1件: Paquinimod---2件: 49, 51 💬
100Paquinimod (ABR-215757)1件: Paquinimod---1件: 49 💬
101PARACETAMOL1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬6件: 3, 6, 13, 35, 46, 49 💬
102Paracetamol (acetaminophen)1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 46 💬
103Paracetamol 120Mg/5mL Oral Suspension1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 3 💬
104PARACETAMOLO----9件: 2, 11, 14, 19, 28, 53, 61, 63, 300 💬
105Paracetamolo 500 mg----1件: 13 💬
106PARACETAMOLO DC.IT FU----1件: 46 💬
107PARACETAMOLO DOC GENERICI - 1000 MG COMPRESSA 16 COMPRESSE----1件: 19 💬
108PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE----1件: 300 💬
109Paracetamolo Zentiva Italia----1件: 28 💬
110Paraclisib----1件: 61 💬
111Paraffin Oil1件: Mineral oil1件: Mineral oil 💬 --1件: 291 💬
112PARALEN 500----1件: 46 💬
113Parapres----1件: 6 💬
114Parathyroid hormon 1-84----1件: 235 💬
115Parathyroid hormone1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTH2R 💬
3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬2件: 70, 235 💬
116Parathyroid Hormone (1-84) Human Recombinant1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTH2R 💬
3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
117Parathyroid Hormone (rDNA)1件: Parathyroid hormone1件: Parathyroid hormone 💬 2件: PTH1R,
PTH2R 💬
3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action 💬1件: 235 💬
118Parathyroideahormon----1件: 235 💬
119PARCOPA2件: Carbidopa,
Levodopa
2件: Levodopa ,
Carbidopa 💬
6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
120Pardaprunox----1件: 6 💬
121Pardoprunox1件: Pardoprunox1件: Pardoprunox 💬 3件: DRD2,
DRD3,
HTR1A 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
122Pardoprunox hydrochloride1件: Pardoprunox1件: Pardoprunox 💬 3件: DRD2,
DRD3,
HTR1A 💬
10件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬1件: 6 💬
123Parecoxib1件: Parecoxib1件: Parecoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬2件: 46, 271 💬
124Parenteral Remodulin (treprostinil) injection1件: Treprostinil1件: Treprostinil 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
125Parenteral Treprostinil1件: Treprostinil1件: Treprostinil 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
126Paricalcitol1件: Paricalcitol1件: Paricalcitol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬5件: 19, 66, 218, 238, 298 💬
127Parnaparin1件: Parnaparin1件: Adomiparin 💬 1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 97 💬
128PARNAPARIN SODIUM1件: Parnaparin1件: Adomiparin 💬 1件: SERPINC1 💬 1件: Complement and coagulation cascades 💬1件: 97 💬
129Paroxetine1件: Paroxetine1件: Paroxetine 💬 1件: SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 💬4件: 6, 13, 46, 85 💬
130Paroxetine & Prednisolone2件: Paroxetine,
Prednisolone
2件: Prednisolone ,
Paroxetine 💬
2件: NR3C1,
SLC6A4 💬
3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
131Paroxetine hydrochloride 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone
2件: Prednisolone ,
Paroxetine 💬
2件: NR3C1,
SLC6A4 💬
3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
132Paroxetine Hydrochloride tablets 10 & 20 mg and Prednisolone 1 mg BP2件: Paroxetine,
Prednisolone
2件: Prednisolone ,
Paroxetine 💬
2件: NR3C1,
SLC6A4 💬
3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 46 💬
133Parsaclisib1件: Parsaclisib1件: Parsaclisib 💬 1件: PIK3CD 💬 106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬3件: 35, 53, 61 💬
134Parsaclisib (1 mg)1件: Parsaclisib1件: Parsaclisib 💬 1件: PIK3CD 💬 106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61 💬
135Parsaclisib (2.5 mg)1件: Parsaclisib1件: Parsaclisib 💬 1件: PIK3CD 💬 106件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬1件: 61 💬
136Parsaclisinib----1件: 61 💬
137Part 1 Levulan injection----1件: 34 💬
138Part 1 Levulan surface application----1件: 34 💬
139Part 1 Levulan surface application twice----1件: 34 💬
140Part 1 Levulan surface application twice with microneedling----1件: 34 💬
141Part 1, JM-010 component Group A----1件: 6 💬
142Part 1, JM-010 component Group B----1件: 6 💬
143Part 1, JM-010 component Group C----1件: 6 💬
144Part 1: LJN452----1件: 93 💬
145Part 2 Adult Alogabat High Dose (aged 15-17)----1件: 201 💬
146Part 2, JM-010 combination Group A----1件: 6 💬
147Part 2, JM-010 combination Group B----1件: 6 💬
148Part 2, JM-010 component Group C----1件: 6 💬
149Part 2: LJN452 Dose level 1----1件: 93 💬
150Part 2: LJN452 Dose level 2----1件: 93 💬
151Part A----1件: 46 💬
152Part A: 100 mg/mL GSK2618960----1件: 13 💬
153Part B----1件: 46 💬
154Part B Open-Label Extension----1件: 51 💬
155Part B: Dose of GSK2618960 decided from Part A----1件: 13 💬
156Part C: Dose of GSK2618960 decided from Part A and B----1件: 13 💬
157Part I - etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
158Part I - etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
159Part I- naproxen 1000 mg1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
160Part II- etoricoxib 60 mg1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
161Part II- etoricoxib 90 mg1件: Etoricoxib1件: Etoricoxib 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
162Part II- naproxen 1000 mg1件: Naproxen1件: Naproxen 💬 2件: PTGS1,
PTGS2 💬
23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 271 💬
163Partial Enteral Nutrition----1件: 96 💬
164Pasireotida1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
165Pasireotida 3001件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
166Pasireotida 6001件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
167Pasireotida 9001件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
168Pasireotide1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 74, 75 💬
169Pasireotide 0.3mg1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
170Pasireotide 0.6 MG/ML1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
171Pasireotide 0.6mg1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
172Pasireotide 0.9 mg1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
173Pasireotide 20mg1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
174Pasireotide 40mg1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
175Pasireotide 60mg1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
176PASIREOTIDE DIASPARTATE1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
177Pasireotide LAR1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 75 💬
178PASIREOTIDE PAMOATE1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
179Pasireotide s.c.1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
180Pasireotide sub-cutaneous1件: Pasireotide1件: Pasireotide 💬 4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
181Pasireotide with or without cabergoline2件: Cabergoline,
Pasireotide
2件: Cabergoline ,
Pasireotide 💬
6件: DRD2,
PRL,
SSTR1,
SSTR2,
SSTR3,
SSTR5 💬
14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 75 💬
182Pasireotode----1件: 75 💬
183PAT----1件: 160 💬
184PAT-001, 0.1%----1件: 160 💬
185PAT-001, 0.2%----1件: 160 💬
186Patient Current Care----1件: 46 💬
187Patient treated with DMARD----1件: 46 💬
188Patients will be randomized to receive EHP-101----1件: 51 💬
189Patients' existing non-steroidal anti-inflammatory drug (NSAID) at approved doses----1件: 46 💬
190Pazopanib1件: Pazopanib---1件: 227 💬
191PB----2件: 67, 225 💬
192PB006----1件: 13 💬
193PB1046----1件: 86 💬
194PB1046 Injection----1件: 113 💬
195PB1046 Subcutaneous Injection----1件: 86 💬
196PB1046, VIP-ELP1-120, Vasomera----1件: 86 💬
197PBA----1件: 231 💬
198PBF-509----1件: 6 💬
199PBF-677----1件: 97 💬
200PBF-999----1件: 8 💬
201PBF-999 / 160 mg----1件: 8 💬
202PBF-999 / 320 mg----1件: 8 💬
203PBFT02----1件: 127 💬
204PBGM01----1件: 19 💬
205PBI4050----2件: 85, 299 💬
206PBKR03----1件: 19 💬
207PBMC autotransplantation----1件: 2 💬
208PBT2----1件: 8 💬
209PC945----1件: 299 💬
210PCA----1件: 70 💬
211PCCLchimGp91s lentiviral vector transduced CD34+ cells infusion----1件: 65 💬
212PCO371----1件: 235 💬
213PCR polymorphism----1件: 46 💬
214PCT (PureCell Technologies Complex)----1件: 97 💬
215PCV----1件: 13 💬
216PD 0299685----1件: 226 💬
217PD 0299685 at 15mg BID----1件: 226 💬
218PD 0299685 at 30mg BID----1件: 226 💬
219PD 0360324----2件: 46, 84 💬
220PD patients H&Y=1.5-2 Medications OFF----1件: 6 💬
221PD patients H&Y=1.5-2 Medications ON----1件: 6 💬
222PD patients H&Y=3 Medications OFF----1件: 6 💬
223PD patients H&Y=3 Medications ON----1件: 6 💬
224PD vitamin supplementation----1件: 6 💬
225PD-02996851件: PD-0299685---1件: 226 💬
226PD-03259011件: Mirdametinib1件: Mirdametinib 💬 2件: MAP2K1,
MAP2K2 💬
89件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬1件: 34 💬
227PD00377 Na-salt----1件: 85 💬
228PDA001----2件: 46, 96 💬
229PDA001 (cenplacel-L)----1件: 84 💬
230PDE5 inhibitor----1件: 86 💬
231PEA-LUT----1件: 127 💬
232Pectin1件: Pectin1件: Pectin 💬 --1件: 96 💬
233Pednisone----2件: 43, 44 💬
234Peficitinib1件: Peficitinib1件: Peficitinib 💬 3件: JAK1,
JAK2,
JAK3 💬
37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
235PEG----15件: 6, 13, 41, 46, 60, 65, 78, 96, 97, 140, 144, 240, 246, 299, 337 💬
236Peg-Ada----1件: 65 💬
237Peg-Interferon alpha-2b1件: Interferon alfa-2b1件: Interferon alfa-2b 💬 2件: IFNAR1,
IFNAR2 💬
18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 34 💬
238PEG-interleukin-21件: Human interleukin-2---1件: 65 💬
239PEG-liposomal Prednisolone Sodium Phosphate2件: Phosphate ion,
Prednisolone
1件: Prednisolone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬2件: 13, 97 💬
240PEG-rhG-CSF----1件: 60 💬
241PEG-somatropin1件: Somatotropin---1件: 78 💬
242Pegcetacoplam----1件: 2 💬
243PEGCETACOPLAN1件: Pegcetacoplan1件: Pegcetacoplan 💬 1件: C3 💬 17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬4件: 2, 61, 62, 222 💬
244Pegcetacoplan (APL-2)1件: Pegcetacoplan1件: Pegcetacoplan 💬 1件: C3 💬 17件: Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬3件: 2, 61, 62 💬
245Pegfilgrastim1件: Pegfilgrastim1件: Pegfilgrastim 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 60 💬
246Peginesatide1件: Peginesatide1件: Peginesatide 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬1件: 283 💬
247PEGINTERFERON BETA-1A1件: Peginterferon beta-1a1件: Peginterferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬
18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
248Peginterferone beta 1a----1件: 13 💬
249PEGINTERFERONE BETA-1A----1件: 13 💬
250PEGINTERFERONE LAMBDA-1A----1件: 13 💬
251Pegsunercept1件: Pegsunercept1件: Pegsunercept 💬 1件: TNF 💬 67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
252Pegsunercept (PEG sTNF-RI)1件: Pegsunercept1件: Pegsunercept 💬 1件: TNF 💬 67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
253Pegtarviliase----1件: 337 💬
254Pegtibatinase----1件: 337 💬
255PEGUNIGALSIDASE ALFA1件: Pegunigalsidase alfa1件: Pegunigalsidase alfa 💬 --1件: 19 💬
256Pegunigalsidase alpha----1件: 19 💬
257PEGVALIASE1件: Pegvaliase1件: Pegvaliase 💬 1件: PAH 💬 5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
258Pegvaliase-Pqpz1件: Pegvaliase1件: Pegvaliase 💬 1件: PAH 💬 5件: Biosynthesis of amino acids, Folate biosynthesis, Metabolic pathways, Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis 💬1件: 240 💬
259Pegvisomant1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 78, 265 💬
260PEGylated Intereron Beta-1a----1件: 13 💬
261Pegylated interferon alfa1件: Interferon alfa1件: Interferon alfa 💬 2件: IFNAR1,
IFNAR2 💬
18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 96 💬
262Pegylated Interferon Alpha2b----1件: 227 💬
263PEGylated Interferon Beta-1a2件: Human interferon beta,
Interferon beta-1a
1件: Interferon beta-1a 💬 2件: IFNAR1,
IFNAR2 💬
18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
264Pegylated polypeptide hormone of human recombinant origin PEG-hGH----1件: 78 💬
265Pegylated recombinant human growth hormone1件: Somatotropin---1件: 78 💬
266PEGYLATED RECOMBINANT HUMAN HYALURONIDASE PH202件: Hyaluronidase,
Hyaluronidase (human recombinant)
3件: Hyaluronidase ,
Hyaluronidase ,
Hyaluronidase 💬
--1件: 28 💬
267Pegylated Somatropin1件: Somatotropin---1件: 78 💬
268Pelubiprofen1件: Pelubiprofen1件: Pelubiprofen 💬 --1件: 46 💬
269Pelubiprofen 30 mg1件: Pelubiprofen1件: Pelubiprofen 💬 --1件: 46 💬
270Pemafibrate1件: Pemafibrate1件: Pemafibrate 💬 1件: PPARA 💬 10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬1件: 93 💬
271Pembrolizumab1件: Pembrolizumab1件: Pembrolizumab 💬 1件: PDCD1 💬 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬2件: 25, 285 💬
272PEMINE - 150 MG CAPSULE RIGIDE 50 CAPSULE----1件: 171 💬
273PEMIROLAST1件: Pemirolast1件: Pemirolast 💬 --1件: 113 💬
274Pemziviptadil (PB1046) Injection----1件: 86 💬
275PEN+usual care----1件: 96 💬
276Pending----6件: 13, 19, 96, 97, 113, 302 💬
277Penicillamine1件: Penicillamine1件: Penicillamine 💬 --2件: 51, 171 💬
278Pentamidina1件: Pentamidine1件: Pentamidine 💬 --1件: 61 💬
279PENTAMIDINA ISETIONATO1件: Pentamidine1件: Pentamidine 💬 --1件: 61 💬
280Pentamidine1件: Pentamidine1件: Pentamidine 💬 --2件: 61, 65 💬
281Pentasa1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
282Pentasa 2g sachet prolonged release granules (95%)2件: Manganese citrate,
Mesalazine
1件: Mesalamine 💬 --1件: 97 💬
283Pentasa 500 mg Retardtabletten1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
284Pentasa Compact 2g, granulate with prolonged release2件: Manganese citrate,
Mesalazine
1件: Mesalamine 💬 --1件: 97 💬
285Pentasa Compact 4g, granulate with prolonged release2件: Manganese citrate,
Mesalazine
1件: Mesalamine 💬 --1件: 97 💬
286Pentasa enema1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
287Pentasa prolonged release granules 2g2件: Manganese citrate,
Mesalazine
1件: Mesalamine 💬 --1件: 97 💬
288PENTASA Sachet1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
289Pentasa Sachet 1 g1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
290Pentasa Sachet 1 g prolonged release granules2件: Manganese citrate,
Mesalazine
1件: Mesalamine 💬 --1件: 96 💬
291Pentasa Sachet 1g1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
292Pentasa Sachet 2 g1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
293Pentetreotide1件: Pentetreotide1件: Pentetreotide 💬 --1件: 75 💬
294Pentosan Polysulfat SP 54® injection solution----1件: 19 💬
295Pentosan polysulfate1件: Pentosan polysulfate---3件: 19, 26, 226 💬
296PENTOSAN POLYSULFATE SODIUM1件: Pentosan polysulfate---1件: 19 💬
297Pentosan polysulfate sodium 100 mg1件: Pentosan polysulfate---1件: 226 💬
298Pentosan Polysulphate SP54----1件: 19 💬
299Pentosan Polysulphate SP54®----1件: 19 💬
300Pentoxifylline1件: Pentoxifylline1件: Pentoxifylline 💬 --12件: 26, 56, 84, 86, 93, 96, 97, 113, 220, 222, 296, 298 💬
301Pentoxifylline 400 MG1件: Pentoxifylline1件: Pentoxifylline 💬 --1件: 97 💬
302Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping----1件: 113 💬
303Peptidic+Probiotic----1件: 96 💬
304Perampanel1件: Perampanel1件: Perampanel 💬 4件: GRIA1,
GRIA2,
GRIA3,
GRIA4 💬
16件: Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬3件: 2, 6, 144 💬
305Percutaneous sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 51件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬1件: 278 💬
306Perdix----1件: 19 💬
307Peresolimab----1件: 46 💬
308PERFALGAN----1件: 2 💬
309Perflubutane1件: Perflubutane1件: Perflubutane 💬 --2件: 298, 300 💬
310Perfluorinated gas/oxygen mixture1件: Oxygen1件: Oxygen 💬 --1件: 299 💬
311Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265 💬
312Perfusion of treatment Ocrelizumab1件: Ocrelizumab1件: Ocrelizumab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
313Perfusion of treatment Rituximab1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬1件: 13 💬
314PERGOLIDE1件: Pergolide1件: Pergolide 💬 2件: DRD1,
DRD2 💬
11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
315Perhexiline1件: Perhexiline1件: Perhexiline 💬 8件: CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S,
CPT1A,
CPT1B,
CPT1C,
CPT2 💬
47件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 58, 272 💬
316Peri-neural Dexamethasone 1 mg1件: Dexamethasone1件: Dexamethasone 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 46 💬
317Perindopril1件: Perindopril1件: Perindopril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬4件: 58, 113, 167, 222 💬
318Perindopril 2mg Tablets1件: Perindopril1件: Perindopril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 113 💬
319PERINDOPRIL ARGININA2件: Arginine,
Perindopril
2件: Arginine ,
Perindopril 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58 💬
320Perindopril arginine2件: Arginine,
Perindopril
2件: Arginine ,
Perindopril 💬
1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬1件: 58 💬
321Peripheral blood stem cell----1件: 285 💬
322Peripheral Blood Stem Cells----2件: 51, 65 💬
323Permitted DMARDs----1件: 46 💬